July 17, 2024
Article
Findings highlight an increased risk of diabetes, MASLD, and cardiovascular disease in patients with PCOS, with risk varying by PCOS phenotype.
June 20, 2023
Article
An ENDO 2023 analysis of data suggests women with PCOS were at a 47% greater risk of mortality relative to their counterparts without the common endocrine disorder.
February 17, 2023
Article
A systematic review and meta-analysis of data from more than a dozen RCTs provide a comprehensive overview of the effects of metformin plus oral contraceptives compared to oral contraceptives alone in women with polycystic ovary syndrome without obesity.
October 11, 2022
Article
A look at data from 1600 women with PCOS from Alabama and California provides new insight into regional differences in presentation of the disease, including an increased risk of excess hair and insulin resistance.
July 14, 2022
Article
New research suggests being born to a mother with polycystic ovary syndrome was associated with a 32% increase in risk of childhood hospitalizations among offspring.
June 22, 2022
Article
Data from a Johns Hopkins Medicine-led analysis provide insight into the risk of cardiovascular complications among women with polycystic ovary syndrome during delivery hospitalizations compared to their counterparts without PCOS.
May 24, 2022
Article
Data presented at the European Congress of Endocrinology detail genetic and observational associations between obesity, and markers of body composition on the likelihood of developing PCOS later in life.
February 15, 2022
Article
A systematic review and meta-analysis suggest approximately 20% of girls with type 2 diabetes also had polycystic ovary syndrome.
February 01, 2022
Article
Results of a recent study shed light on observational and genetic associations between obesity and multiple female reproductive disorders, including uterine fibroids, PCOS, and heavy menstrual bleeding.
October 15, 2021
Article
A pair of studies provide insight into the increased risk of dysglycemia among women with PCOS and the potential influence of combined oral contraceptive pills on this risk in a population-based cohort.